Common painkillers to remain over the counter until 2017 after ruling delay

By Jane Lee
Updated November 20 2015 - 3:13am, first published 2:14am
The Therapeutic Goods Administration has delayed a decision on whether common painkillers such as Nurofen Plus should continue to be available over the counter.
The Therapeutic Goods Administration has delayed a decision on whether common painkillers such as Nurofen Plus should continue to be available over the counter.

Common painkillers such as Panadeine and Nurofen Plus will be available over the counter for another year, after the Australian drug regulator was inundated by submissions from people opposed to the idea.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options